Back to Article List

TGACC reviews use of GLP-1 receptor agonists as meal replacements or supplements

Australia

Apr 14, 2025

The Therapeutic Goods Advertising Consultative Committee (TGACC) met in Sydney on Thursday 6 March 2025. Members discussed concerns about foods and supplements claiming to complement GLP-1 receptor agonist (GLP-1 RA) use, such as meal replacements or supplements. Members also discussed the impact of economic factors on vitamin supplement consumption. Concerns were raised about the advertising of these products, considering health implications for consumers who substitute fresh fruits and vegetables with supplements.

 

For further information (in English), click on the Link

Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox

®